MedPath
NMPA Approval

Dobutamine Hydrochloride Injection

国药准字H20254389

May 27, 2025

Drug Information

盐酸多巴酚丁胺注射液

注射剂

20ml∶250mg(按C₁₈H₂₃NO₃计)

化学药品

May 27, 2025

Company Information

Applicant Company

成都市温江区成都海峡两岸科技产业开发园

Manufacturing Company

成都市温江区安贤路433号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

盐酸多巴酚丁胺注射液 - NMPA 批准文号 | MedPath